Conference abstract · 29 Sep 2016
Review articlePublished 28 Jul 2020
Define-HF and Emperial Trials: Lessons Learned
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Sodium Glucose co-transporter inhibitors (SGLT-2i) have firmly established their position in the management of type 2 diabetes mellitus (T2DM) and have also expanded their indication for use. There were different outcomes benefits with the three SGLT-2i, resulting from differences in patient population studied, primary end-points chosen and statistical testing hierarchy. Although the outcome benefits complemented each other, the subtle differences were blown out of proportion by interested lobbies, eyeing a larger pie of the market share. The corporate war intensified with the publication and top-line results of 2 two recent symptom-based trials in patients with heart failure (DEFINEHF & EMPERIAL). Once again, the differences were subtle and there were more similarities than differences. Diuretics provide the desired symptom relief whereas SGLT-2i are associated with hard end-point outcome benefits. In view of the profound benefits associated with the use of SGLT-2i two additional categories of studies were launched. The first explored the area of symptomatic relief and the second concentrated on the mechanistic benefits. This review looks in depth at the different types of trials conducted with SGLT-2i and their similarities which is supported by all the recently published guidelines.
Keywords
Subjects
Diabetes & EndocrinologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Other · 30 Jul 2016
Pioglitazone: lessons and learnings 15 years since launch and beyond
Review article · 7 Jul 2016
Addressing diabetes racial and ethnic disparities: lessons learned from quality improvement collaboratives
Conference abstract · 25 Aug 2015
Using Transcriptomics to Guide Lead Optimization in Drug Discovery Projects: Lessons Learned from the QSTAR Project
Perspective · 6 May 2025
Lessons to be Learned from the CEASE-AF Trial Comparing Hybrid Epi and Endocardial Ablation to Endocardial Catheter Ablation Alone in Advanced Atrial Fibrillation
More from this journal
The newest in Journal of Diabetes & Metabolism.
Rapid communication · 29 May 2025
Community diabetes prevention: Effective, global impact
Rapid communication · 29 May 2025
Genetic and epigenetic markers for gdm risk
Short communication · 29 May 2025
Metabolic syndrome: Diet, timed eating, supplements
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Diabetes & Metabolism
- SubjectDiabetes & Endocrinology
- BylineArticles whose byline prints “Samit Ghosal”
